Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
18 Leser
Artikel bewerten:
(0)

VNUS Medical Technologies Appoints Kirti Kamdar as Senior Vice President of Research & Development

SAN JOSE, Calif., Dec. 3 /PRNewswire-FirstCall/ -- VNUS(R) Medical Technologies, Inc. , a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, today announced the appointment of Kirti Kamdar as Senior Vice President of Research & Development.

Mr. Kamdar joins VNUS with 20 years of research and development experience in the medical device industry. Most recently, he served as Senior Vice President at Cardiac Dimensions, Inc., a privately held medical device company. Prior to Cardiac Dimensions, he held various senior leadership and management positions at Vascular Architects, Somnus Medical Technologies and Mallinckrodt Medical. Mr. Kamdar holds a MS degree in Polymer Engineering and Science from the New Jersey Institute of Technology, and an executive MBA from the University of Houston.

VNUS President and Chief Executive Officer Brian Farley stated, "Kirti's broad R&D expertise in catheters, radiofrequency products, and polymer science is enhanced by his broad skills in clinical and regulatory affairs as well as quality systems. These combined skills along with Kirti's long track record of bringing many successful medical devices to the market and in leading research and development organizations make him a highly welcome addition to the VNUS organization and Senior Management Team."

About VNUS Medical Technologies, Inc.

VNUS is a leading provider of medical devices for the minimally invasive treatment of venous reflux disease, a progressive condition that is often the underlying cause of painful varicose veins. VNUS sells the Closure(R) system, which consists of a proprietary radiofrequency (RF) generator and proprietary disposable endovenous catheters and devices to close diseased veins through the application of temperature-controlled RF energy. Approximately 300,000 patients have been treated to date with VNUS Closure catheters. For more information, please visit the corporate website at http://www.vnus.com/ .

Kupfer - Jetzt! So gelingt der Einstieg in den Rohstoff-Trend!
In diesem kostenfreien Report schaut sich Carsten Stork den Kupfer-Trend im Detail an und gibt konkrete Produkte zum Einstieg an die Hand.
Hier klicken
© 2007 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.